The UKs pilot scheme offering free chlamydia testing in pharmacies is to be applauded but a number of issues need to be resolved if it is to be a success, concludes an editorial in this weeks issue of The Lancet.
Chlamydia is the most common bacterial sexually transmitted disease. Recent reports suggest that more than 10 percent of Japanese teenagers are infected with chlamydia, that the incidence of chlamydia infection in
The Lancet comments: Although pharmacists are experts in providing medicines and guidance about their use, will adequate training and staffing be available to explain the testing process and the meaning of the results, be they positive or negative? How will the testing process be linked to the provision of follow up for those testing positive whether or not they receive treatment? Who will provide the sexual contact tracing facilities for people with newly diagnosed sexual infections? Who will provide safe sex advice, and who will address the issues of testing for other STIs in an at risk population? These difficult and sensitive issues require careful consideration if the governments innovation is to be a success.
Source: The Lancet